Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
United Imaging unveiled its complete radiotherapy portfolio at ESTRO 2026 in Stockholm, featuring the CE-marked uRT-linac 506c system with integrated diagnostic CT and adaptive AI-driven treatment capabilities.
Virtual Science AI has launched Medical Competitor AI, a platform that uses artificial intelligence to analyze competitor medical activities and scientific narratives for pharmaceutical companies.
Accuray Incorporated and the University of Wisconsin School of Medicine and Public Health have entered a 10-year research agreement to develop personalized cancer treatments using Accuray's Stellar adaptive radiation therapy platform.
Enlil announced a record first quarter of 2026, signing eight new MedTech customers that migrated from legacy quality and product lifecycle systems to its AI powered traceability platform.
Psynk AI has announced a partnership with Ocean View Psychiatric Hospital to pilot its AI psychiatric assistant in an inpatient setting, supporting documentation, patient assessment, and care coordination.
Orbis International and Siloam Vision have introduced artificial intelligence screening for premature babies in Mongolia to detect retinopathy of prematurity, the leading cause of childhood blindness worldwide.
ELLKAY has appointed Lucky Singh as Chief Technology Officer to lead its technology and AI strategy, focusing on advancing healthcare data interoperability and intelligent automation.
Optura has secured $17.5 million in Series A funding led by Salesforce Ventures, with participation from Echo Health Ventures and others, to expand its ROAI platform for measuring AI investment value in healthcare.
Urologic Health has secured $11 million in seed funding to advance its catheter-free bladder function monitoring system and prepare for U.S. market entry.
InsideTracker has launched Terra, a neurosymbolic AI platform designed to help wellness businesses deliver individualized, evidence-based health guidance at scale. The system integrates multiple health data sources to generate transparent, science-backed recommendations.
Enlil reported a record first quarter of 2026, securing eight new MedTech customers who adopted its AI-powered traceability platform after moving away from legacy quality and product lifecycle systems.
Saile has raised $2.2 million in an oversubscribed pre-seed round led by Matchstick Ventures to improve healthcare staffing and credentialing. The platform uses AI agents to automate recruitment, onboarding, and compliance across various care settings.
EMA Wellness has formed an exclusive partnership with Mira Analytics to apply AI models for endpoint validation and rater surveillance in global central nervous system clinical trials, integrating these capabilities into EMAW's data platform.
Minset announced that its autonomous medical coding system, mCoder, achieved state-of-the-art results on the MDACE benchmark, surpassing all prior peer-reviewed results across both constrained and full-label evaluations.
Supreme Group has launched Supreme Intelligence FDE+, described as the first Forward Deployed Expert model designed specifically for healthcare and life sciences. The model integrates domain expertise with the Supreme Intelligence platform to deliver custom AI solutions for clients in regulated medical fields.
German pharmaceutical company CHEPLAPHARM has implemented TraceLink's Multienterprise Information Network Tower (MINT) to automate and standardize its global supply chain operations, enabling real-time data exchange and improved efficiency across its partner network.
Hippocratic AI has announced six senior executive appointments to strengthen its leadership across strategy, legal, revenue, communications, and customer success functions as it scales its healthcare AI platform.
Zifo has launched an AI enabled data migration solution that automates complex scientific data transfers while maintaining compliance and validation for industries such as biopharma.
Datar Cancer Genetics has received U.S. FDA clearance for its CellDx Tissue assay, a comprehensive genomic profiling test for solid tumors that analyzes DNA and RNA to identify key cancer-related genetic variations.
Ozelle received the German Innovation Award Gold for its EHBT-50 Mini Lab, a multifunctional diagnostic system that integrates hematology, biochemistry, immunoassay, and AI-assisted morphology analysis into one platform designed for decentralized clinical environments.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
